Congenital biliary atresia in an infant born to hepatitis B mother treated with telbivudine before and during pregnancy

Dig Liver Dis. 2018 Oct;50(10):1097-1098. doi: 10.1016/j.dld.2018.07.030. Epub 2018 Aug 1.

Authors

Ruofei Wang¹, Shanshun Fang¹, Qingming Sun¹, Yi-Hua Zhou²

Affiliations

¹ Department of Infectious Diseases, Jiangsu Armed Police General Hospital, Yangzhou, Jiangsu, China.
² Departments of Laboratory Medicine and Infectious Diseases, Nanjing Drum Tower Hospital and Jiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Jiangsu, China; Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing Medical University, Jiangsu, China. Electronic address: [email protected].

PMID: 30115574
DOI: 10.1016/j.dld.2018.07.030

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use*
Biliary Atresia / chemically induced
Biliary Atresia / diagnostic imaging*
Biliary Atresia / surgery
Carcinoma, Hepatocellular / therapy
Carcinoma, Hepatocellular / virology
Fatal Outcome
Female
Hepatitis B / complications
Hepatitis B / drug therapy*
Humans
Infant
Infectious Disease Transmission, Vertical / prevention & control
Liver Neoplasms / therapy
Liver Neoplasms / virology
Male
Pregnancy
Telbivudine / adverse effects
Telbivudine / therapeutic use*

Substances

Antiviral Agents
Telbivudine